Mission & Vision
Mission
To expand patient access to critical medicines by developing niche generic formulations of originator molecules — enabled by proprietary, complex drug delivery systems designed to match or exceed innovator performance.
Vision
To be the global partner of choice for high-barrier generics across soft gels, nasal delivery, high-volume depot injections, and microneedle technologies — delivering affordable therapies without compromise on quality, safety, or science.
Complex molecules. Elegant solutions. Real patient impact.
Our Perspective
“At Landmark Medicines, we believe the future of generics lies not in replication, but in intelligent re-engineering. By combining scientific depth with proprietary delivery technologies, we aim to unlock the full therapeutic potential of drugs old and new — making advanced treatments more accessible to patients worldwide.”
Scientific & Strategic Approach
We focus on the intersection of formulation science, delivery innovation, and regulatory precision — targeting niche, technically demanding opportunities where meaningful differentiation is possible.
Our work is grounded in:
Deep expertise in complex drug delivery systems
A disciplined focus on high-barrier generic opportunities
Robust, cGMP-aligned development practices
A commitment to performance parity with innovator products
Facilities & Capabilities
Our facilities are located in the university town of Loughborough, United Kingdom, within a leading academic and scientific ecosystem. Our laboratories are purpose-built to support the development of complex generics across multiple advanced delivery platforms.
State-of-the-art R&D infrastructure includes:
Integrated formulation, analytical, and stability laboratories
Soft gel encapsulation capabilities
Nasal delivery development and characterisation systems
High-volume depot injection development suites
Microneedle research and fabrication environments
This integrated environment enables rapid iteration from concept through to development, with a strong emphasis on scalability and regulatory readiness.
Quality & Compliance
Our operations are built around globally recognised quality standards and regulatory expectations:
cGMP-aligned quality systems
ISO 13485-compliant processes for device-integrated platforms
Designed for FDA and EMA regulatory pathways
Established frameworks for partner audits and technology transfer